Francesco Caso

InstitutionUniversity Federico II
AddressNaples
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in May 2020 and July 2021
    All Publications
    Bar chart showing 112 publications over 13 distinct years, with a maximum of 25 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Maione F, Casillo GM, Raucci F, Salvatore C, Ambrosini G, Costa L, Scarpa R, Caso F, Bucci M. Interleukin-17A (IL-17A): A silent amplifier of COVID-19. Biomed Pharmacother. 2021 Oct; 142:111980. PMID: 34364043.
      Citations:    Fields:    Translation:Humans
    2. Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol. 2021 07 08; 61(1):45. PMID: 34238376.
      Citations:    Fields:    Translation:Humans
    3. Ursini F, Ruscitti P, D'Angelo S, Cacciapaglia F, De Angelis R, Campochiaro C, Caso F, De Santis M, Di Cola I, Parisi S, Raimondo V, Abignano G, Costa L, Ciaffi J, Dagna L, Iagnocco A, Iannone F, Meliconi R, Giacomelli R, Ferri C. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. Ann Rheum Dis. 2021 11; 80(11):1498-1501. PMID: 34039622.
      Citations:    Fields:    Translation:Humans
    4. Scarpa R, Caso F, Costa L, Passavanti S, Vitale MG, Trojaniello C, Del Puente A, Ascierto PA. May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? J Transl Med. 2020 12 22; 18(1):489. PMID: 33353549.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    5. Caso F, Del Puente A, Girolimetto N, Tasso M, Caso C, Scarpa R, Costa L. Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al. Ann Rheum Dis. 2020 Jul 28. PMID: 32723750.
      Citations: 3     Fields:    
    6. Costa L, Tasso M, Scotti N, Mostacciuolo E, Girolimetto N, Foglia F, Del Puente A, Scarpa R, Caso F. Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort. Ann Rheum Dis. 2020 Jun 11. PMID: 32527866.
      Citations: 4     Fields:    
    7. Raucci F, Mansour AA, Casillo GM, Saviano A, Caso F, Scarpa R, Mascolo N, Iqbal AJ, Maione F. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev. 2020 07; 19(7):102572. PMID: 32376393.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    8. Vastarella M, Patrì A, Annunziata MC, Cantelli M, Nappa P, Tasso M, Costa L, Caso F, Fabbrocini G. Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment. J Am Acad Dermatol. 2020 07; 83(1):e77-e79. PMID: 32360856.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    9. Scarpa R, Costa L, Del Puente A, Caso F. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype. Pediatr Neonatol. 2020 06; 61(3):364-365. PMID: 32317217.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    10. Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, Scarpa R. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020 May; 19(5):102524. PMID: 32220633.
      Citations: 59     Fields:    Translation:HumansCells